156 related articles for article (PubMed ID: 19296678)
1. Crystal structures of constitutive nitric oxide synthases in complex with de novo designed inhibitors.
Igarashi J; Li H; Jamal J; Ji H; Fang J; Lawton GR; Silverman RB; Poulos TL
J Med Chem; 2009 Apr; 52(7):2060-6. PubMed ID: 19296678
[TBL] [Abstract][Full Text] [Related]
2. Structures of human constitutive nitric oxide synthases.
Li H; Jamal J; Plaza C; Pineda SH; Chreifi G; Jing Q; Cinelli MA; Silverman RB; Poulos TL
Acta Crystallogr D Biol Crystallogr; 2014 Oct; 70(Pt 10):2667-74. PubMed ID: 25286850
[TBL] [Abstract][Full Text] [Related]
3. Electrostatic Control of Isoform Selective Inhibitor Binding in Nitric Oxide Synthase.
Li H; Wang HY; Kang S; Silverman RB; Poulos TL
Biochemistry; 2016 Jul; 55(26):3702-7. PubMed ID: 27250740
[TBL] [Abstract][Full Text] [Related]
4. Insights into the structural determinants for selective inhibition of nitric oxide synthase isoforms.
Oliveira BL; Moreira IS; Fernandes PA; Ramos MJ; Santos I; Correia JD
J Mol Model; 2013 Apr; 19(4):1537-51. PubMed ID: 23263357
[TBL] [Abstract][Full Text] [Related]
5. Exploring the binding conformations of bulkier dipeptide amide inhibitors in constitutive nitric oxide synthases.
Li H; Flinspach ML; Igarashi J; Jamal J; Yang W; Gómez-Vidal JA; Litzinger EA; Huang H; Erdal EP; Silverman RB; Poulos TL
Biochemistry; 2005 Nov; 44(46):15222-9. PubMed ID: 16285725
[TBL] [Abstract][Full Text] [Related]
6. In search of potent and selective inhibitors of neuronal nitric oxide synthase with more simple structures.
Jing Q; Li H; Fang J; Roman LJ; Martásek P; Poulos TL; Silverman RB
Bioorg Med Chem; 2013 Sep; 21(17):5323-31. PubMed ID: 23867386
[TBL] [Abstract][Full Text] [Related]
7. Role of zinc in isoform-selective inhibitor binding to neuronal nitric oxide synthase .
Delker SL; Xue F; Li H; Jamal J; Silverman RB; Poulos TL
Biochemistry; 2010 Dec; 49(51):10803-10. PubMed ID: 21138269
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.
Flinspach ML; Li H; Jamal J; Yang W; Huang H; Hah JM; Gómez-Vidal JA; Litzinger EA; Silverman RB; Poulos TL
Nat Struct Mol Biol; 2004 Jan; 11(1):54-9. PubMed ID: 14718923
[TBL] [Abstract][Full Text] [Related]
9. Improved synthesis of chiral pyrrolidine inhibitors and their binding properties to neuronal nitric oxide synthase.
Xue F; Kraus JM; Labby KJ; Ji H; Mataka J; Xia G; Li H; Delker SL; Roman LJ; Martásek P; Poulos TL; Silverman RB
J Med Chem; 2011 Sep; 54(18):6399-403. PubMed ID: 21809851
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for isoform-selective inhibition in nitric oxide synthase.
Poulos TL; Li H
Acc Chem Res; 2013 Feb; 46(2):390-8. PubMed ID: 23030042
[TBL] [Abstract][Full Text] [Related]
11. Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase.
Li H; Xue F; Kraus JM; Ji H; Labby KJ; Mataka J; Delker SL; Martásek P; Roman LJ; Poulos TL; Silverman RB
Bioorg Med Chem; 2013 Mar; 21(5):1333-43. PubMed ID: 23352768
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the active site of neuronal nitric oxide synthase by the design and synthesis of pyrrolidinomethyl 2-aminopyridine derivatives.
Ji H; Delker SL; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2010 Nov; 53(21):7804-24. PubMed ID: 20958055
[TBL] [Abstract][Full Text] [Related]
13. Structures of the neuronal and endothelial nitric oxide synthase heme domain with D-nitroarginine-containing dipeptide inhibitors bound.
Flinspach M; Li H; Jamal J; Yang W; Huang H; Silverman RB; Poulos TL
Biochemistry; 2004 May; 43(18):5181-7. PubMed ID: 15122883
[TBL] [Abstract][Full Text] [Related]
14. Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase.
Xue F; Fang J; Delker SL; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2011 Apr; 54(7):2039-48. PubMed ID: 21410186
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided design of selective inhibitors of neuronal nitric oxide synthase.
Huang H; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2013 Apr; 56(7):3024-32. PubMed ID: 23451760
[TBL] [Abstract][Full Text] [Related]
16. Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.
Silverman RB
Acc Chem Res; 2009 Mar; 42(3):439-51. PubMed ID: 19154146
[TBL] [Abstract][Full Text] [Related]
17. First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate.
Cinelli MA; Reidl CT; Li H; Chreifi G; Poulos TL; Silverman RB
J Med Chem; 2020 May; 63(9):4528-4554. PubMed ID: 32302123
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthase.
Xue F; Huang J; Ji H; Fang J; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
Bioorg Med Chem; 2010 Sep; 18(17):6526-37. PubMed ID: 20673724
[TBL] [Abstract][Full Text] [Related]
19. 2-Aminopyridines with a Truncated Side Chain To Improve Human Neuronal Nitric Oxide Synthase Inhibitory Potency and Selectivity.
Kang S; Li H; Tang W; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2015 Jul; 58(14):5548-60. PubMed ID: 26120733
[TBL] [Abstract][Full Text] [Related]
20. 2-Aminopyridines with a shortened amino sidechain as potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors.
Vasu D; Li H; Hardy CD; Poulos TL; Silverman RB
Bioorg Med Chem; 2022 Sep; 69():116878. PubMed ID: 35772285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
